山东大学耳鼻喉眼学报 ›› 2020, Vol. 34 ›› Issue (4): 125-129.doi: 10.6040/j.issn.1673-3770.0.2019.355

• 综述 • 上一篇    下一篇

变应性鼻炎中信号传导通路的研究进展

黄嘉莉1综述杨淑荣2审校   

  1. 黄嘉莉1 综述杨淑荣2 审校1.江西中医药大学临床医学院, 江西 南昌 3300002.江西中医药大学附属医院 耳鼻喉科, 江西 南昌 330000
  • 收稿日期:2019-07-15 出版日期:2020-07-20 发布日期:2020-08-28
  • 基金资助:
    江西中医药大学校级研究生创新专项资金项目(JZYC18S31)

Advances in research on related signaling pathways in allergic rhinitisHUANG Jiali1 Review YANG Shurong2Guidance 1.Department of Clinical Medicine, Jiangxi University of Traditional Chinese Medicine,Nanchang 330000, Jiangxi, China 2.Department of Otolaryngology, Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang 330000, Jiangxi, ChinaAbstract:

The occurrence and development of allergic rhinitis involves a variety of signal transduction pathways. Studying signal transduction pathways can promote the progress of pathogenesis research, suggesting that we can block the conduction of pathways in a pathway to achieve therapeutic effects. Open up new prospects for designing and developing more effective new drug treatments.The common signaling pathways in allergic rhinitis are reviewed in this article to provide a reference for the treatment of allergic rhinitis.   

  1. Key words: Allergic rhinitis;
    Signal transduction;
    Pathway;
    Nosogenesis 变应性鼻炎(allergic rhinitis, AR)是变态反应性疾病中最常见的上呼吸道疾病, 从西方发达国家已有的数据来看, 未来随着人民生活环境清洁度的提高, AR的发病率也会呈上升趋势[1-2]。信号转导是变应性疾病发病机制研究的一大热点, 近年来关于变应性疾病中信号传导通路的研究日益增多, 对各信号通路的发病机制的研究, 有助于寻找到有效的干预途径, 达到预防与治疗AR的目的。
  • Received:2019-07-15 Online:2020-07-20 Published:2020-08-28

摘要: 变应性鼻炎发生及发展的过程涉及多种信号传导通路,研究信号传导通路可以推动发病机制的研究进展,提示应用某一通路中的阻断剂阻断通路传导以达到治疗作用,为设计开发更有效新型药物治疗开拓新的前景。综述变应性鼻炎中常见的信号传导通路,为治疗变应性鼻炎提供参考。

关键词: 变应性鼻炎, 信号转导, 通路, 发病机制

Abstract: The occurrence and development of allergic rhinitis involves a variety of signal transduction pathways. Studying signal transduction pathways can promote the progress of pathogenesis research, suggesting that we can block the conduction of pathways in a pathway to achieve therapeutic effects. Open up new prospects for designing and developing more effective new drug treatments.The common signaling pathways in allergic rhinitis are reviewed in this article to provide a reference for the treatment of allergic rhinitis.

Key words: Allergic rhinitis, Signal transduction, Pathway, Nosogenesis

中图分类号: 

  • R765
[1] Krajewska-Wojtys A,Jarzab J,Zawadzińska K,et al.Local Allergic rhinitis in adult patients with chronic nasal symptoms[J].Int Arch Allergy Immunol, 2017, 173(3): 165-170. doi: 10.1159/000478656.
[2] Rondón C,Canto G,Blanca M. Local allergic rhinitis: a new entity,characterization and further studies[J]. Curr Opin Allergy Clin Immu-nol, 2010, 10( 1): 1-7. doi: 10.1097/ACI.0b013e328334f5fb.
[3] 韩德民, 张罗, GLAUS BACHERGT, 等. 过敏性鼻炎[M]. 2版. 北京:人民卫生出版社, 2014.
[4] 陈若希, 张清照, 陆美萍, 等. TLR通路基因多态性与变应性鼻炎的关联研究[J]. 山东大学耳鼻喉眼学报, 2019,33(3):79-87. doi:10.6040/j.issn.1673-3770.1. 2019.008. CHEN Ruoxi, ZHANG Qingzhao, LU Meiping, et al. Association of Toll-like receptor pathway gene polymorphisms with allergic rhinitis[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3):79-87. doi:10.6040/j.issn.1673-3770.1.2019.008.
[5] TIAN Shaohua, YU Dejun, LI Zhiyong, et al. The inhibition of microRNA-203 on ischemic reperfusion injury after total knee arthroplasty via suppressing MYD88-mdiated toll-like receptor signaling pathway[J]. Gene, 2019. doi:10.1016/j.gene.2019.02.030
[6] Deguine J, Barton GM. MyD88: a central player in innate immune signaling[J]. Prime Reports, 2014, 6(97):97. doi: 10.12703/P6-97.
[7] De Nardo D. Toll-like receptors: Activation, signalling and transcriptional modulation[J]. Cytokine, 2015,74(2):181-189. doi: 10.1016/j.cyto. 2015.02.025.
[8] 徐吉, 李吉平. 变应性鼻炎与TLR/MyD88信号通路[J]. 中华耳鼻咽喉头颈外科杂志, 2014(1):80-82. doi:10.3760/cma.j.issn.1673-0860. 2014.01.026.
[9] 林甦, 黄敬之. 玉屏风散对变应性鼻炎模型大鼠TLR4/NF-κB信号通路的影响[J]. 中国中医药信息杂志, 2018, 25(12):48-52. doi:10.3969/j.issn.1005-5304.2018.12.013. LIN Su, HUANG Jinzhi. Effects of Yupingfeng powder on TLR4/NF-κB signaling pathway of model rats with allergic rhinitis[J]. Chin J Information on Traditional Chin Med, 2018,25(12):48-52. doi:10.3969/j.issn.1005-5304.2018.12.013.
[10] LI Jin, ZHANG Lili, CHEN Xin, et al. Pollen/TLR4 Innate immunity signaling initiates IL-33/ST2/Th2 pathways in allergic inflammation[J]. Scientific reports, 2016,6. doi:10.1038/srep36150.
[11] Jafarzadeh Abdollah, Nemati Maryam, Khorramdelazad Hossain, et al. The Toll-like Receptor 2(TLR2)-related immunopathological responses in the multiple sclerosis and experimental autoimmune encephalomyelitis[J]. Iranian Journal of Allergy, Asthma, and Immunology, 2019,18(3). doi:10.18502/ijaai.v18i3.1117.
[12] 杨春治. 雷公藤内酯醇对大鼠变应性鼻炎TLR2-NF-κB信号通路的干预作用[J]. 山西医科大学学报, 2015,46(7):636-640. doi:10.13753/j.issn.1007-6611. 2015.07.008. YANG Chunzhi. Effect of triptolide on TLR2-NF-κB signaling pathway of allergic rhinitis in rats[J]. J Shanxi Med University.2015,46(7):636-640. doi:10.13753/j.issn.1007-6611.2015.07.008.
[13] Duronio V,Scheid MP,Ettinger S. Downstream signalling events reg-ulated by phosphatidylinositol 3-kinase activity. Cell Signalling,1998(10):233-239. doi: 10.1016/s0898-6568(97)00129-0.
[14] Shang AQ, Wu J, Bi F, et al. Relationship between HER2 and JAK/STAT -SOCS3 signaling pathway and clinicopathological features and prognosis of ovarian cancer[J]. Cancer Biol Ther,2017,18( 5 ): 314-322. doi: 10.1080/15384047.2017.1310343.
[15] Ji X, Han M, Yun Y, et al. Acute nitrogen dioxide(NO2)exposure en-hances airway inflammation via modulating Th1 / Th2 differentiation andactivating JAK-STAT pathway [J]. Chemosphere,2015,120:722-728. doi: 10.1016/j.chemosphere.2014.10.039.
[16] Welsch K,Holstein J,Laurence A, et al. Targeting JAK/START signalling in inflammatory skin diseases with small molecule inhibitors [J]. Eur J lmmunol, 2017,47(7):1096-1107. doi: 10.1002/eji.201646680.
[17] 陈晓萍, 徐飞. JAK-STAT信号通路研究进展[J]. 自然杂志, 2003(3):149-152. doi:10.3969/j.issn.0253-9608. 2003.03.007. CHEN Xiaoping, XU Fei. Progress in the studies of JAK-STAT signal pathway[J]. Chin J Nature,2003(3):149-152. doi:10.3969/j.issn.0253-9608.2003.03.007.
[18] 孟欣, 张晓敏, 戴启刚, 等. IL-33/ST2信号转导通路与过敏性鼻炎的研究进展[J]. 中华中医药杂志, 2015,30(6):2032-2035. MENG Xin, ZHANG Xiaomin, DAI Qigang, et al. Research progress on the role of IL-33/ST2 signal path in allergic rhinitis[J]. Chin J Traditional Chin Med Pharmacy, 2015, 30(6):2032-2035.
[19] Lam EP, Kariyawasam HH, Rana BM. Et al. IL-25/IL-33-responsive TH2 cells characterize nasal polyps with a default TH17 signature in nasal mucosa[J]. Journal of Allergy and Clinical Immunology,2016,137(5). doi: 10.1016/j.jaci.2015.10.019.
[20] 王书敬, 赵长青. 肥大细胞表面受体在变应性鼻炎中的作用[J].中国眼耳鼻喉科杂志, 2014,14(4):261-264. doi:10.14166/j.issn.1671-2420.2014.04.021.
[21] 庄翔莉, 吴博, 邱彩霞, 等. 醒鼻凝胶滴鼻剂对变应性鼻炎豚鼠鼻黏膜成纤维细胞Fyn-STAT5信号通路的影响[J]. 中华中医药杂志, 2018, 33(5):1794-1799. ZHUANG Xiangli, WU Bo, QIU Caixia, et al. Effects of Xingbi Gel on Fyn-STAT5 pathway in nasal mucosa fibroblasts of allergic rhinitis guinea pigs[J].Chin J Traditional Chin Med Pharmacy, 2018,33(5):1794-1799.
[22] 陈建勇, 王聪, 王娟, 等. MAPK信号通路研究进展[J]. 中国医药科学, 2011,1(8):32-34.
[23] 王振霖, 李鹏, 李源, 等. p38丝裂原激活蛋白激酶通路对变应性鼻炎中黏蛋白5AC的信号转导机制初探[J]. 临床耳鼻咽喉头颈外科杂志, 2011,25(20):943-946. doi:10.3969/j.issn.1001-1781.2011.20.010. WANG Zhenlin, LI Peng, LI Yuan, et al. A preliminary study on the regulation mechanism of p38MAPK on MUC5AC in allergic rhinitis[J]. J Clinical Otorhinolaryngol Head and Neck Surgery, 2011, 25(20):943-946. doi:10.3969/j.issn.1001-1781. 2011.20.010.
[24] Jung HW, Jung JK, Park YK. Antiallergic effect of Ostericum koreanum root extract on ovalbumin-induced allergic rhinitis mouse model and mast cells [J]. Asian Pac J Allergy lmmunol, 2011, 29:338-348.
[25] 程雷. 同一气道, 同一疾病: 舌下免疫治疗的临床应用[J]. 山东大学耳鼻喉眼学报, 2019,33(1):1-3. doi:10.6040/j.issn.1673-3770.1.2018.048. CHENG Lei. One airway, one disease:clinical application of sublingual immunotherapy[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019,33(1):1-3. doi:10.6040/j.issn.1673-3770.1.2018.048.
[26] 周远红. JNK 信号通路在变应性鼻炎小鼠发病机制中的研究[D]. 武汉;华中科技大学,2010.
[27] 杨淑荣, 杨小军, 谢强, 等. 基于外周血EOS-骨髓通路研究谢氏“温督祛霾”针灸法治疗变应性鼻炎的疗效与机制[J]. 实用中西医结合临床,2019,19(1):1-3,65. doi:10.13638/j.issn.1671-4040. 2019.01.001. YANG Shurong, YANG Xiaojun, XIE Qiang, et al. The Study on the therapeutic effect and mechanism of Xies “Wenduqumai” acupuncture and moxibustion therapy on allergic rhinitis based on peripheral blood eos-bone marrow pathway [J]. Practical Clinical J Integrated Traditional Chin Western Med,2019,19(1):1-3,65. doi:10.13638/j.issn.1671-4040. 2019.01.001.
[28] 张丽霞, 刘涛. Treg通过TICAM-1通路对变应性鼻炎发病机制的影响[J]. 临床耳鼻咽喉头颈外科杂志, 2018,32(22):1763-1766. doi:10.13201/j.issn.1001-1781. 2018.22.020. ZHANG Lixia, LIU Tao. Treg influences the pathogenesis of allergic rhinitis through TICAM-1 pathway[J].J Clinical Otorhinolaryngol Head and Neck Surgery, 2018, 32(22):1763-1766. doi:10.13201/j.issn.1001-1781.2018.22.020.
[29] 戴炳译. B细胞信号传导通路中SYK等因子的变化致变应性鼻炎发作机制的研究[D]. 扬州:扬州大学,2018.
[1] 林晓芹综述吴苗琴审校. 特发性视网膜前膜的发病机制及治疗进展[J]. 山东大学耳鼻喉眼学报, 2020, 34(2): 121-128.
[2] 田秋实,胡文婷,逄明杰. 变应性鼻炎鼻分泌物嗜酸性粒细胞与肺功能相关性研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(6): 52-55.
[3] 刘小涵,张小兵. PU.1转录因子和辅助性Th9细胞与变应性鼻炎[J]. 山东大学耳鼻喉眼学报, 2019, 33(5): 139-143.
[4] 张贵阳,黄河,冼志,张汉文,谢桂彩. 粉尘螨滴剂舌下含服免疫治疗对不同年龄段变应性鼻炎患者的临床效果评估[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 60-65.
[5] 刘燕,魏萍,寇巍,胡思洁,武小芳,刘萌雅,陈成,姚红兵. 儿童腺样体肥大与耳鼻咽喉科常见疾病关系的研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(4): 149-154.
[6] 钱俊俊,周文成,吴中飞,卜冬云,汪李琴,陆美萍,程雷. 苏皖地区变应性鼻炎患者吸入性变应原谱分析[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 147-151.
[7] 田慧琴,吴中飞,陆莹,程雷. GCCYP27B1基因多态性与汉族人群尘螨致敏的持续性变应性鼻炎的关联研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 71-78.
[8] 陈若希,张清照,陆美萍,朱歆洁,程雷. TLR通路基因多态性与变应性鼻炎的关联研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 79-87.
[9] 陆美萍,程雷. 变应性鼻炎的遗传学研究现状[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 36-41.
[10] 孙子雯,崔洪玮,孙喜灵,陈晨,张璐,胡竹林. 干眼病的病因、发病机制及治疗进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(2): 159-166.
[11] 郭胤仕,卢慧. Ⅱ型固有淋巴细胞在变应性鼻炎发病机制中的作用[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 9-12.
[12] 邱前辉,高俊潇. 特异性免疫治疗对过敏性鼻炎和哮喘的同步控制和远期疗效[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 33-37.
[13] 张宇,宋西成. 慢性鼻窦炎伴鼻息肉与哮喘的相关性机制及治疗策略研究进展[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 49-52.
[14] 秦雅楠,王琳,姜彦,闫舒,陈敏,于龙刚,李娜. 2008~2017年青岛地区变应性鼻炎常见吸入性变应原分布[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 67-72.
[15] 金兴,胡大宇,朱丽,邓芙蓉,刘俊秀. PM2.5与变应性鼻炎患者上气道阻力的相关性研究[J]. 山东大学耳鼻喉眼学报, 2019, 33(1): 77-80.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!